Literature DB >> 7927542

Peptide motifs of HLA-DR4/DR53 (DRB1*0405/DRB4*0101) molecules.

R Kinouchi1, H Kobayasi, K Sato, S Kimura, M Katagiri.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7927542     DOI： 10.1007/bf01246679

Source DB:  PubMed          Journal:  Immunogenetics        ISSN： 0093-7711            Impact factor:   2.846


× No keyword cloud information.
  14 in total

1.  Different length peptides bind to HLA-Aw68 similarly at their ends but bulge out in the middle.

Authors:  H C Guo; T S Jardetzky; T P Garrett; W S Lane; J L Strominger; D C Wiley
Journal:  Nature       Date:  1992-11-26       Impact factor: 49.962

2.  Isolation of an endogenously processed immunodominant viral peptide from the class I H-2Kb molecule.

Authors:  G M Van Bleek; S G Nathenson
Journal:  Nature       Date:  1990-11-15       Impact factor: 49.962

3.  Effect of natural polymorphism at residue 86 of the HLA-DR beta chain on peptide binding.

Authors:  R Busch; C M Hill; J D Hayball; J R Lamb; J B Rothbard
Journal:  J Immunol       Date:  1991-08-15       Impact factor: 5.422

4.  HLA DR4w4-binding motifs illustrate the biochemical basis of degeneracy and specificity in peptide-DR interactions.

Authors:  A Sette; J Sidney; C Oseroff; M F del Guercio; S Southwood; T Arrhenius; M F Powell; S M Colón; F C Gaeta; H M Grey
Journal:  J Immunol       Date:  1993-09-15       Impact factor: 5.422

5.  Characterization of endogenous peptides bound to purified HLA-DR molecules and their absence from invariant chain-associated alpha beta dimers.

Authors:  J R Newcomb; P Cresswell
Journal:  J Immunol       Date:  1993-01-15       Impact factor: 5.422

6.  Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1.

Authors:  J H Brown; T S Jardetzky; J C Gorga; L J Stern; R G Urban; J L Strominger; D C Wiley
Journal:  Nature       Date:  1993-07-01       Impact factor: 49.962

7.  Promiscuous and allele-specific anchors in HLA-DR-binding peptides.

Authors:  J Hammer; P Valsasnini; K Tolba; D Bolin; J Higelin; B Takacs; F Sinigaglia
Journal:  Cell       Date:  1993-07-16       Impact factor: 41.582

8.  [Immunogenetic and molecular genetic studies on ocular diseases].

Authors:  S Ohno
Journal:  Nippon Ganka Gakkai Zasshi       Date:  1992-12

9.  Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles.

Authors:  R M Chicz; R G Urban; J C Gorga; D A Vignali; W S Lane; J L Strominger
Journal:  J Exp Med       Date:  1993-07-01       Impact factor: 14.307

10.  Direct binding of a myasthenia gravis related epitope to MHC class II molecules on living murine antigen-presenting cells.

Authors:  E Mozes; M Dayan; E Zisman; S Brocke; A Licht; I Pecht
Journal:  EMBO J       Date:  1989-12-20       Impact factor: 11.598
View more
  8 in total

Review 1.  Molecular aspects of type 1 diabetes.

Authors:  M A Kelly; M L Rayner; C H Mijovic; A H Barnett
Journal:  Mol Pathol       Date:  2003-02

2.  The interplay between citrullination and HLA-DRB1 polymorphism in shaping peptide binding hierarchies in rheumatoid arthritis.

Authors:  Yi Tian Ting; Jan Petersen; Sri H Ramarathinam; Stephen W Scally; Khai L Loh; Ranjeny Thomas; Anish Suri; Daniel G Baker; Anthony W Purcell; Hugh H Reid; Jamie Rossjohn
Journal:  J Biol Chem       Date:  2018-01-09       Impact factor: 5.157

3.  Naturally processed HLA-DR9/DR53 (DRB1*0901/DRB4*0101)-bound peptides.

Authors:  G Futaki; H Kobayashi; K Sato; M Taneichi; M Katagiri
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

Review 4.  MHC ligands and peptide motifs: first listing.

Authors:  H G Rammensee; T Friede; S Stevanoviíc
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

5.  The role of MHC class II molecules in susceptibility to type I diabetes: identification of peptide epitopes and characterization of the T cell repertoire.

Authors:  C C Chao; H K Sytwu; E L Chen; J Toma; H O McDevitt
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-03       Impact factor: 11.205

6.  Identification and antigenicity of broadly cross-reactive and conserved human immunodeficiency virus type 1-derived helper T-lymphocyte epitopes.

Authors:  C C Wilson; B Palmer; S Southwood; J Sidney; Y Higashimoto; E Appella; R Chesnut; A Sette; B D Livingston
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

7.  The increased ability to present citrullinated peptides is not unique to HLA-SE molecules: arginine-to-citrulline conversion also enhances peptide affinity for HLA-DQ molecules.

Authors:  Arieke S B Kampstra; Jurgen van Heemst; Antonis K Moustakas; George K Papadopoulos; Tom W J Huizinga; René E M Toes
Journal:  Arthritis Res Ther       Date:  2016-11-03       Impact factor: 5.156

8.  Analysis of naturally processed human histocompatibility leukocyte antigen class I-bound peptides from hepatocellular carcinoma tissues in vivo.

Authors:  H Kobayashi; K Sato; N Miyokawa; S Kimura; M Nakashima; M Katagiri
Journal:  Jpn J Cancer Res       Date:  1995-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.